↓ Skip to main content

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)

Overview of attention for article published in Trials, March 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
39 Mendeley